Interestingly, it has been reported that SF3B1 is frequently mutated in many types of human cancers, including myelodysplastic syndrome (MDS), chronic lymphocytic leukemia, breast cancer, uveal melanoma, and PDAC [26, 27, 28, 29, 30]. Here, SF3B1 is linked to breast carcinoma.